<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-65716" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Protein C and S</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Padda</surname>
            <given-names>Inderbir S.</given-names>
          </name>
          <aff>Richmond University Medical Center/Mount Sinai</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Poras</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Citla Sridhar</surname>
            <given-names>Divyaswathi</given-names>
          </name>
          <aff>Rainbow Babies &#x00026; Children&#x02019;s Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Inderbir Padda declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Poras Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Divyaswathi Citla Sridhar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-65716.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Protein C and protein S are glycoproteins, predominantly synthesized in the liver, that&#x000a0;are important components of the natural anticoagulant system in the body.<xref ref-type="bibr" rid="article-65716.r1">[1]</xref><xref ref-type="bibr" rid="article-65716.r2">[2]</xref>&#x000a0;They are Vitamin K dependent and serve as essential components in maintaining physiologic hemostasis.<xref ref-type="bibr" rid="article-65716.r1">[1]</xref></p>
        <p>A deficiency of protein C and protein S results in the loss of these natural anticoagulant properties, resulting in unchecked thrombin generation and thromboembolism.</p>
      </sec>
      <sec id="article-65716.s2" sec-type="Etiology and Epidemiology">
        <title>Etiology and Epidemiology</title>
        <p>Protein C and&#x000a0;S deficiencies&#x000a0;can be secondary to inherited gene mutations or due to acquired causes.<xref ref-type="bibr" rid="article-65716.r3">[3]</xref><xref ref-type="bibr" rid="article-65716.r1">[1]</xref><xref ref-type="bibr" rid="article-65716.r4">[4]</xref>&#x000a0;Most inherited forms are secondary to missense mutations (60% to 70%), followed by smaller percentages (1% to 15%) of nonsense mutations, splice site mutations, large deletions, small deletions/duplications/insertions, and point mutations.<xref ref-type="bibr" rid="article-65716.r5">[5]</xref></p>
        <p>
<bold>Protein C Deficiency</bold>
</p>
        <p>In the healthy general population, the incidence of asymptomatic protein C deficiency is 1 in 200 to 500 individuals, while clinically significant venous thromboembolism is estimated to occur in 1 in 20,000 individuals.<xref ref-type="bibr" rid="article-65716.r6">[6]</xref>&#x000a0;No clear racial or ethnic predispositions are known.<xref ref-type="bibr" rid="article-65716.r7">[7]</xref></p>
        <p>Protein C deficiency may be inherited or acquired.</p>
        <p>The inherited form of protein C deficiency&#x000a0;is typically an autosomal recessive disorder; however, de novo mutations have been reported. Approximately 160 mutations in the protein C gene (PROC) located on chromosome 2q14.3 have been described in the literature.<xref ref-type="bibr" rid="article-65716.r8">[8]</xref>&#x000a0;These mutations fall into two general types. Type I deficiency is characterized by a low protein C antigen and activity levels.<xref ref-type="bibr" rid="article-65716.r9">[9]</xref>&#x000a0;Type II deficiency is characterized by normal&#x000a0;protein C antigen levels but low protein C activity levels.<xref ref-type="bibr" rid="article-65716.r9">[9]</xref></p>
        <p>Protein C deficiency may also be acquired by one of several mechanisms. Newborns may have physiologically low levels of protein C at birth; levels have been reported to be as low as 35% in otherwise healthy full-term infants. This is an age-related acquired form of protein C deficiency; protein C levels&#x000a0;increase to the lower level of the adult reference range by 6 to 12 months of age.<xref ref-type="bibr" rid="article-65716.r10">[10]</xref>&#x000a0;Other causes of acquired protein C deficiency include inflammatory or infectious processes, liver disease, malignancies, chemotherapeutics, disseminated intravascular coagulopathy, and vitamin K deficiency or the use of vitamin K antagonist medications.<xref ref-type="bibr" rid="article-65716.r7">[7]</xref><xref ref-type="bibr" rid="article-65716.r11">[11]</xref><xref ref-type="bibr" rid="article-65716.r12">[12]</xref>&#x000a0;Of note, warfarin results in a transient procoagulant state with a reduction of protein C levels; there is a small risk of severe warfarin-induced skin necrosis in patients with an underlying hereditary protein C deficiency.</p>
        <p>
<bold>Protein S Deficiency&#x000a0;</bold>
<xref ref-type="bibr" rid="article-65716.r13">[13]</xref>
<xref ref-type="bibr" rid="article-65716.r14">[14]</xref>
</p>
        <p>The exact prevalence of protein S deficiency in the general population is unknown. However, some studies have estimated a prevalence of 0.03% to 0.13% in healthy individuals.<xref ref-type="bibr" rid="article-65716.r14">[14]</xref></p>
        <p>Protein S deficiency may also be inherited or acquired.</p>
        <p>The inherited form of protein S deficiency is typically an autosomal dominant disorder. The PROS1 gene is located on chromosome&#x000a0;3q11.1, and approximately 200 mutations in this gene have been described in the literature.<xref ref-type="bibr" rid="article-65716.r15">[15]</xref>&#x000a0;Three distinct types of protein S deficiency have been identified; the defect is quantitative in type I and III but qualitative in type II.<xref ref-type="bibr" rid="article-65716.r14">[14]</xref>&#x000a0;</p>
        <p>Type I protein S deficiency is the most common type and is characterized by a low total protein S level, low free protein S level, and low protein S activity. Type II deficiency is characterized by a normal free and total protein S level but low protein S activity levels.&#x000a0;Type II deficiency is a rare form of the disease.&#x000a0;Type III protein S deficiency is characterized by normal total protein S levels but low free protein S levels and low&#x000a0;protein S activity.</p>
        <p>Protein S deficiency may also be acquired by one of several mechanisms. Newborns may have low levels of protein S at birth; levels increase to the adult reference range by 6 to 10 months of age, typically sooner than protein C levels.<xref ref-type="bibr" rid="article-65716.r16">[16]</xref>&#x000a0;Other acquired causes of protein S deficiency include liver disease, infection, inflammation, nephrotic syndrome, disseminated intravascular coagulopathy, chemotherapy, malignancy, pregnancy, combined oral contraceptive use, hormone replacement therapy, vitamin K deficiency, and the use of vitamin K antagonists.<xref ref-type="bibr" rid="article-65716.r11">[11]</xref><xref ref-type="bibr" rid="article-65716.r7">[7]</xref><xref ref-type="bibr" rid="article-65716.r17">[17]</xref>&#x000a0;Though warfarin-induced skin necrosis is typically described in protein C deficiency, rare cases in protein S deficiency have also been reported in the literature.<xref ref-type="bibr" rid="article-65716.r18">[18]</xref></p>
      </sec>
      <sec id="article-65716.s3" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Protein C and protein S are primarily synthesized in the liver. Protein S is also synthesized by platelets, endothelial cells, osteoblasts, and vascular smooth muscle cells and circulates in plasma.<xref ref-type="bibr" rid="article-65716.r7">[7]</xref>&#x000a0;</p>
        <p>Protein C is&#x000a0;activated by the thrombin-thrombomodulin complex to form activated protein C (APC) on the surface of the vascular endothelial cells.<xref ref-type="bibr" rid="article-65716.r1">[1]</xref>&#x000a0;Once protein C is activated, free protein S in the plasma is a cofactor, along with phospholipids and calcium, to inactivate factor V and factor VIIIa&#x000a0;at specific&#x000a0;polypeptide arginine cleavage sites.<xref ref-type="bibr" rid="article-65716.r1">[1]</xref>&#x000a0;This results in impaired prothrombin activation, thereby exerting their anti-coagulant action by reducing thrombin generation.&#x000a0;About 60% to 70% of protein S is bound,&#x000a0;noncovalently attached to C4-binding protein (CBP).<xref ref-type="bibr" rid="article-65716.r19">[19]</xref><xref ref-type="bibr" rid="article-65716.r20">[20]</xref>&#x000a0;This protein S-CBP complex enhances the cleavage of activated factor Va but not as effectively as free protein S.<xref ref-type="bibr" rid="article-65716.r20">[20]</xref><xref ref-type="bibr" rid="article-65716.r21">[21]</xref>&#x000a0;Protein S also enhances the effects of APC in fibrinolysis.&#x000a0;Protein S also exerts APC-independent effects by directly inhibiting the tenase &#x00026; prothrombinase complex, acting as an important cofactor to tissue factor pathway inhibitor (TFPI) during the inactivation of activated factor X and further inhibiting thrombin generation.<xref ref-type="bibr" rid="article-65716.r14">[14]</xref>&#x000a0;&#x000a0;</p>
        <p>In protein C or protein S deficiency, the coagulation cascade continues unchecked with the overactivity of factor V and factor VIII, resulting in excessive&#x000a0;thrombin production.<xref ref-type="bibr" rid="article-65716.r1">[1]</xref><xref ref-type="bibr" rid="article-65716.r2">[2]</xref><xref ref-type="bibr" rid="article-65716.r21">[21]</xref></p>
        <p>Mutations to factor V (G1691A) in the activated protein C resistance disorder&#x000a0;can prevent deactivation even in the presence of proteins C and S, promoting blood clotting.<xref ref-type="bibr" rid="article-65716.r3">[3]</xref><xref ref-type="bibr" rid="article-65716.r22">[22]</xref>&#x000a0;The resistance comes from a single nucleotide point mutation of adenine to guanine,&#x000a0;further changing the polypeptide arginine to glutamine at the cleavage site of factor V&#x000a0;and causing resistance to cleavage.<xref ref-type="bibr" rid="article-65716.r3">[3]</xref></p>
      </sec>
      <sec id="article-65716.s4" sec-type="Specimen Requirements and Procedure">
        <title>Specimen Requirements and Procedure</title>
        <p>Proteins C- and S-antigen and activity levels are usually performed by collecting a venous blood sample in citrate. These samples are centrifuged in the laboratory to separate the plasma. The plasma is&#x000a0;frozen in aliquots and stored at -80^oC until analysis.&#x000a0;</p>
        <p>The typical volume of&#x000a0;plasma required is 0.5 mL per 2.7 mL. The plasma needs to be frozen within four hours of collection.&#x000a0;</p>
        <p>The patient should discontinue warfarin for at least two weeks before drawing the sample.</p>
        <p>It is crucial to perform protein C and S testing several weeks after an acute thrombosis or inflammatory condition to allow serum levels to return to baseline.<xref ref-type="bibr" rid="article-65716.r1">[1]</xref></p>
      </sec>
      <sec id="article-65716.s5" sec-type="Diagnostic Tests">
        <title>Diagnostic Tests</title>
        <p>
<bold>Protein C Deficiency</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Protein C functional assay - This is the preferred assay in the clinical setting, as this can help identify both type I and type II disorders. Available options include factor Xa-based, activated partial thromboplastin time (aPTT) based, or a chromogenic assay.</p>
          </list-item>
          <list-item>
            <p>Total protein C - Measured by immunoassay. This helps distinguish type I and type II deficiencies.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Mutational analysis - PROC1 mutation testing is done once the initial testing suggests underlying protein C deficiency. This can help provide genetic counseling to patients and to understand the natural history of the disease.<xref ref-type="bibr" rid="article-65716.r23">[23]</xref><xref ref-type="bibr" rid="article-65716.r13">[13]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Protein S Deficiency</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Total protein S - Measured by immunoassay. Other detection methods include ligand-based or monoclonal antibody-based methods.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Free protein S -&#x000a0;Measured by immunoassay. Antibody-based methods are also used in some laboratories.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Protein S functional assay - Measured by a clot-based assay. The amount of protein S activity is proportional to the time to clot formation.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Mutational analysis - PROS1 mutation testing is done once the initial testing suggests underlying protein S deficiency.<xref ref-type="bibr" rid="article-65716.r23">[23]</xref><xref ref-type="bibr" rid="article-65716.r13">[13]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-65716.s6" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Interfering factors include the presence of the lupus anticoagulant, factor V Leiden mutations, APC resistance, elevated plasma factor VIII levels, and hyperlipidemia.<xref ref-type="bibr" rid="article-65716.r21">[21]</xref></p>
        <p>Functional protein S assays&#x000a0;should be employed alongside the free protein S immunoassays&#x000a0;due to various&#x000a0;interferences&#x000a0;during testing.<xref ref-type="bibr" rid="article-65716.r19">[19]</xref>&#x000a0;These interferences in laboratory testing may disrupt analysis, resulting in false positive or false negative outcomes.<xref ref-type="bibr" rid="article-65716.r24">[24]</xref></p>
      </sec>
      <sec id="article-65716.s7" sec-type="Results, Reporting, and Critical Findings&#x0000d;&#x0000a;">
        <title>Results, Reporting, and Critical Findings
</title>
        <p>Normal reference ranges for proteins C and S are age-dependent.<xref ref-type="bibr" rid="article-65716.r25">[25]</xref> They are as follows:</p>
        <p>
<bold>Protein C [IU/dL, Mean (range)]</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>1-5 years: 66 (40-92)</p>
          </list-item>
          <list-item>
            <p>6-10 years: 69 (45-93)</p>
          </list-item>
          <list-item>
            <p>11-16 years: 83 (55-110)</p>
          </list-item>
          <list-item>
            <p>Adult: 96 (64-128)</p>
          </list-item>
        </list>
        <p>
<bold>Total Protein S [IU/dL, mean (range)]</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>1-5 years: 86 (54-118)</p>
          </list-item>
          <list-item>
            <p>6-10 years: 78 (41-114)</p>
          </list-item>
          <list-item>
            <p>11-16 years: 72 (52-92)</p>
          </list-item>
          <list-item>
            <p>Adult: 81 (60-113)</p>
          </list-item>
        </list>
        <p>
<bold>Free Protein S [IU/dL, Mean (range)]</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>1-5 years: 45 (21-69)</p>
          </list-item>
          <list-item>
            <p>6-10 years: 42 (22-62)</p>
          </list-item>
          <list-item>
            <p>11-16 years: 38 (26-55)</p>
          </list-item>
          <list-item>
            <p>Adult: 45 (27-61)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-65716.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Patients with hereditary defects of the protein C and protein S pathways are&#x000a0;prone&#x000a0;to thromboembolic events such as deep venous thrombosis, pulmonary embolism, stroke, and organ ischemia.<xref ref-type="bibr" rid="article-65716.r23">[23]</xref><xref ref-type="bibr" rid="article-65716.r7">[7]</xref><xref ref-type="bibr" rid="article-65716.r26">[26]</xref>&#x000a0;Venous thromboembolism&#x000a0;is more common than arterial.&#x000a0;Patients who inherit heterozygous alleles for protein C or protein S deficiency will present with an onset later during adulthood compared to individuals who inherit homozygous alleles; homozygous mutations frequently present with critical&#x000a0;blood clotting complexities at birth, such as purpura fulminans.<xref ref-type="bibr" rid="article-65716.r7">[7]</xref><xref ref-type="bibr" rid="article-65716.r4">[4]</xref>&#x000a0;Patients are also at risk for thromboembolism during high estrogenic states such as pregnancy and combined oral contraceptive use.<xref ref-type="bibr" rid="article-65716.r27">[27]</xref>&#x000a0;<bold/><bold>Treatment</bold></p>
        <p>The long-term treatment for protein C and S deficiencies is anticoagulation with heparin bridged to warfarin. The medications should overlap for five days until the therapeutic range of the international normalized ratio (INR) of 2.0 to 3.0 is reached for two consecutive days.<xref ref-type="bibr" rid="article-65716.r14">[14]</xref><xref ref-type="bibr" rid="article-65716.r28">[28]</xref><xref ref-type="bibr" rid="article-65716.r7">[7]</xref>&#x000a0;Protein C concentrate can be used as replacement therapy for protein C deficiency.<xref ref-type="bibr" rid="article-65716.r7">[7]</xref>&#x000a0;In homozygous&#x000a0;newborns suffering from hemorrhagic and thrombotic complications of purpura fulminans, protein C concentrate in the form of fresh frozen plasma can be given.<xref ref-type="bibr" rid="article-65716.r7">[7]</xref></p>
        <p>The warfarin dose should be carefully assessed and bridged with a therapeutic dose of heparin as it can impose warfarin-induced skin necrosis in protein C and S deficiency. Warfarin inhibits the Vitamin K-dependent clotting factors and proteins C and S. Warfarin-induced skin necrosis transpires due to the relatively short half-life of proteins C and S, which are inhibited first when warfarin is administered. This further promotes the procoagulant effects of other vitamin K-dependent clotting factors and forms microthrombi.<xref ref-type="bibr" rid="article-65716.r29">[29]</xref><xref ref-type="bibr" rid="article-65716.r30">[30]</xref></p>
        <p>
<bold>Monitoring</bold>
</p>
        <p>Patients prescribed warfarin&#x000a0;for long-term use warrant recurrent monitoring to confirm the medication is in the optimal range and that benefits exceed the risk of harm.<xref ref-type="bibr" rid="article-65716.r28">[28]</xref>&#x000a0;The medication should be carefully assessed regularly so the INR is in the therapeutic range.<xref ref-type="bibr" rid="article-65716.r28">[28]</xref></p>
      </sec>
      <sec id="article-65716.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Proteins C and S are glycoproteins synthesized in the liver, which function to maintain the physiologic function of coagulation within the body. When mutated or dysfunctional, they can cause symptoms of blood clotting in all ages, with onset from birth to late adulthood. These thrombophilias prompt care from interprofessional healthcare teams, which include primary care providers, hematologists, nurses, and pharmacists.</p>
        <p>This team-based approach provides an integrated, evidence-based strategy to treat patients with symptomatic thrombophilias and monitor asymptomatic thrombophilias. The interprofessional team should be up-to-date with the latest management guidelines for anticoagulation use and regularly monitor the INR to maintain therapeutic ranges. Patients should be educated on their disease, medication compliance, and factors that may interfere with medication to cause sub-therapeutic or toxic levels. Genetic counseling should be offered to at-risk patients with a history of thrombophilia or a family history of the disease. The interprofessional team should be able to inform their patients about the risk and probability of the condition being transmitted to offspring.</p>
        <p>The care of protein C and protein S deficiency is most beneficial when managed in an interprofessional team strategy to form a therapeutic alliance and enhance patient-centered care to achieve the desired outcome.<xref ref-type="bibr" rid="article-65716.r27">[27]</xref><xref ref-type="bibr" rid="article-65716.r13">[13]</xref><xref ref-type="bibr" rid="article-65716.r23">[23]</xref></p>
      </sec>
      <sec id="article-65716.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=65716&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=65716">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/65716/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=65716">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-65716.s11">
        <title>References</title>
        <ref id="article-65716.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wypasek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Undas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Protein C and protein S deficiency - practical diagnostic issues.</article-title>
            <source>Adv Clin Exp Med</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>459</fpage>
            <page-range>459-67</page-range>
            <pub-id pub-id-type="pmid">23986205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hepner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karlaftis</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Protein C.</article-title>
            <source>Methods Mol Biol</source>
            <year>2013</year>
            <volume>992</volume>
            <fpage>365</fpage>
            <page-range>365-72</page-range>
            <pub-id pub-id-type="pmid">23546729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sedano-Balb&#x000e1;s</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cleary</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gaffney</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maher</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.</article-title>
            <source>J Pregnancy</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>232840</fpage>
            <pub-id pub-id-type="pmid">21869933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aiach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borgel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gaussem</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Emmerich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alhenc-Gelas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gandrille</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Protein C and protein S deficiencies.</article-title>
            <source>Semin Hematol</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-16</page-range>
            <pub-id pub-id-type="pmid">9241706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rezende</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Simmonds</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex.</article-title>
            <source>Blood</source>
            <year>2004</year>
            <month>Feb</month>
            <day>15</day>
            <volume>103</volume>
            <issue>4</issue>
            <fpage>1192</fpage>
            <page-range>1192-201</page-range>
            <pub-id pub-id-type="pmid">12907438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dahlb&#x000e4;ck</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The protein C anticoagulant system: inherited defects as basis for venous thrombosis.</article-title>
            <source>Thromb Res</source>
            <year>1995</year>
            <month>Jan</month>
            <day>01</day>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-43</page-range>
            <pub-id pub-id-type="pmid">7701473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldenberg</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Manco-Johnson</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Protein C deficiency.</article-title>
            <source>Haemophilia</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1214</fpage>
            <page-range>1214-21</page-range>
            <pub-id pub-id-type="pmid">19141162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khor</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Van Cott</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Laboratory tests for protein C deficiency.</article-title>
            <source>Am J Hematol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>440</fpage>
            <page-range>440-2</page-range>
            <pub-id pub-id-type="pmid">20309856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reitsma</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Bernardi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Doig</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Gandrille</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Greengard</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ireland</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Krawczak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lind</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Poort</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH.</article-title>
            <source>Thromb Haemost</source>
            <year>1995</year>
            <month>May</month>
            <volume>73</volume>
            <issue>5</issue>
            <fpage>876</fpage>
            <page-range>876-89</page-range>
            <pub-id pub-id-type="pmid">7482420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishiguro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaneko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>T</given-names>
              </name>
              <collab>Japan Childhood Thrombophilia Study Group</collab>
            </person-group>
            <article-title>Protein C deficiency as the major cause of thrombophilias in childhood.</article-title>
            <source>Pediatr Int</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-71</page-range>
            <pub-id pub-id-type="pmid">23521084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walker</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Protein C deficiency in liver disease.</article-title>
            <source>Ann Clin Lab Sci</source>
            <year>1990</year>
            <season>Mar-Apr</season>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-12</page-range>
            <pub-id pub-id-type="pmid">2183701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Unal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Varan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yal&#x000e7;in</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>B&#x000fc;y&#x000fc;kpamuk&#x000e7;u</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000fc;rgey</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of thrombotic children with malignancy.</article-title>
            <source>Ann Hematol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>395</fpage>
            <page-range>395-9</page-range>
            <pub-id pub-id-type="pmid">15735962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tun</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tuma</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <chapter-title>Protein S Deficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>12</month>
            <day>5</day>
            <pub-id pub-id-type="pmid">31335064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ten Kate</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>van der Meer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Protein S deficiency: a clinical perspective.</article-title>
            <source>Haemophilia</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1222</fpage>
            <page-range>1222-8</page-range>
            <pub-id pub-id-type="pmid">18479427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gandrille</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Borgel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sala</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Espinosa-Parrilla</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Simmonds</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rezende</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lind</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mannhalter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pabinger</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Reitsma</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Formstone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bernardi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aiach</surname>
                <given-names>M</given-names>
              </name>
              <collab>Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis</collab>
            </person-group>
            <article-title>Protein S deficiency: a database of mutations--summary of the first update.</article-title>
            <source>Thromb Haemost</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>918</fpage>
            <pub-id pub-id-type="pmid">11127877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sthoeger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karpatkin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Protein S in the first year of life.</article-title>
            <source>Br J Haematol</source>
            <year>1989</year>
            <month>Jul</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>424</fpage>
            <page-range>424-8</page-range>
            <pub-id pub-id-type="pmid">2527552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kemkes-Matthes</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Acquired protein S deficiency.</article-title>
            <source>Clin Investig</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>70</volume>
            <issue>6</issue>
            <fpage>529</fpage>
            <page-range>529-34</page-range>
            <pub-id pub-id-type="pmid">1392420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grimaudo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gueissaz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hauert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sarraj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kruithof</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Necrosis of skin induced by coumarin in a patient deficient in protein S.</article-title>
            <source>BMJ</source>
            <year>1989</year>
            <month>Jan</month>
            <day>28</day>
            <volume>298</volume>
            <issue>6668</issue>
            <fpage>233</fpage>
            <page-range>233-4</page-range>
            <pub-id pub-id-type="pmid">2522326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guermazi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Conard</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Congenital protein S deficiencies; diagnostic difficulties].</article-title>
            <source>Pathol Biol (Paris)</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>483</fpage>
            <page-range>483-7</page-range>
            <pub-id pub-id-type="pmid">18583066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amiral</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seghatchian</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Revisiting the activated protein C-protein S-thrombomodulin ternary pathway: Impact of new understanding on its laboratory investigation.</article-title>
            <source>Transfus Apher Sci</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>538</fpage>
            <page-range>538-544</page-range>
            <pub-id pub-id-type="pmid">31256946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hepner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karlaftis</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Protein S.</article-title>
            <source>Methods Mol Biol</source>
            <year>2013</year>
            <volume>992</volume>
            <fpage>373</fpage>
            <page-range>373-81</page-range>
            <pub-id pub-id-type="pmid">23546730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amiral</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vissac</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Seghatchian</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay.</article-title>
            <source>Transfus Apher Sci</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>6</issue>
            <fpage>906</fpage>
            <page-range>906-913</page-range>
            <pub-id pub-id-type="pmid">29162399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r23">
          <label>23</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patibandla</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Protein C Deficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">31194379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dinarvand</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Protein C Deficiency.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>143</volume>
            <issue>10</issue>
            <fpage>1281</fpage>
            <page-range>1281-1285</page-range>
            <pub-id pub-id-type="pmid">30702334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrew</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vegh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bowker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ofosu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Maturation of the hemostatic system during childhood.</article-title>
            <source>Blood</source>
            <year>1992</year>
            <month>Oct</month>
            <day>15</day>
            <volume>80</volume>
            <issue>8</issue>
            <fpage>1998</fpage>
            <page-range>1998-2005</page-range>
            <pub-id pub-id-type="pmid">1391957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michiels</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hamuly&#x000e1;k</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Laboratory diagnosis of hereditary thrombophilia.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>1998</year>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>309</fpage>
            <page-range>309-20</page-range>
            <pub-id pub-id-type="pmid">9763348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r27">
          <label>27</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kujovich</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <chapter-title>Factor V Leiden Thrombophilia</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bean</surname>
                <given-names>LJH</given-names>
              </name>
              <name>
                <surname>Gripp</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1999</year>
            <month>5</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">20301542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kujovich</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Factor V Leiden thrombophilia.</article-title>
            <source>Genet Med</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-16</page-range>
            <pub-id pub-id-type="pmid">21116184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraga</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Diniz</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Emerich</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Warfarin-induced skin necrosis in a patient with protein S deficiency.</article-title>
            <source>An Bras Dermatol</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>93</volume>
            <issue>4</issue>
            <fpage>612</fpage>
            <page-range>612-613</page-range>
            <pub-id pub-id-type="pmid">30066782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-65716.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pourdeyhimi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bullard</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Warfarin-induced skin necrosis.</article-title>
            <source>Hosp Pharm</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>11</issue>
            <fpage>1044</fpage>
            <page-range>1044-8</page-range>
            <pub-id pub-id-type="pmid">25673894</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
